These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 33165628)
1. Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literature. Meriggi F; Zaniboni A Cancer Immunol Immunother; 2021 Jun; 70(6):1511-1517. PubMed ID: 33165628 [TBL] [Abstract][Full Text] [Related]
2. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? Elkrief A; Derosa L; Kroemer G; Zitvogel L; Routy B Ann Oncol; 2019 Oct; 30(10):1572-1579. PubMed ID: 31268133 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models. Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic and Modulation of Microbiota: A New Paradigm? Rizzatti G; Ianiro G; Gasbarrini A J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755 [TBL] [Abstract][Full Text] [Related]
5. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications. Lee KA; Shaw HM; Bataille V; Nathan P; Spector TD Eur J Cancer; 2020 Oct; 138():149-155. PubMed ID: 32889369 [TBL] [Abstract][Full Text] [Related]
6. [The role of intestinal microbiota in the response to anti-tumor therapies]. Vétizou M; Daillère R; Zitvogel L Med Sci (Paris); 2016 Nov; 32(11):974-982. PubMed ID: 28008838 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic-induced dysbiosis effects on the murine gastrointestinal tract and their systemic repercussions. Rosa CP; Brancaglion GA; Miyauchi-Tavares TM; Corsetti PP; de Almeida LA Life Sci; 2018 Aug; 207():480-491. PubMed ID: 30056862 [TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications. Guven DC; Aktas BY; Simsek C; Aksoy S Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. Thänert R; Thänert A; Ou J; Bajinting A; Burnham CD; Engelstad HJ; Tecos ME; Ndao IM; Hall-Moore C; Rouggly-Nickless C; Carl MA; Rubin DC; Davidson NO; Tarr PI; Warner BB; Dantas G; Warner BW Gut Microbes; 2021; 13(1):1940792. PubMed ID: 34264786 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiome in primary sclerosing cholangitis: A review. Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effects of different fucoidans on cefoperazone-induced gut microbiota disturbance and intestinal inflammation. Luo J; Wang Z; Fan B; Wang L; Liu M; An Z; Zhao X Food Funct; 2021 Oct; 12(19):9087-9097. PubMed ID: 34388231 [TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota in Cancer Immune Response and Immunotherapy. Zhou CB; Zhou YL; Fang JY Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230 [TBL] [Abstract][Full Text] [Related]
14. Role of mucositis in predicting gut microbiota composition in people with cancer. Scott JS; Li A; Wardill HR Curr Opin Support Palliat Care; 2024 Jun; 18(2):73-77. PubMed ID: 38652454 [TBL] [Abstract][Full Text] [Related]
15. Fucoidan isolated from Ascophyllum nodosum alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice. Wang L; Ai C; Wen C; Qin Y; Liu Z; Wang L; Gong Y; Su C; Wang Z; Song S Food Funct; 2020 Jun; 11(6):5595-5606. PubMed ID: 32525182 [TBL] [Abstract][Full Text] [Related]
16. Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment. Yang X; Guo Y; Chen C; Shao B; Zhao L; Zhou Q; Liu J; Wang G; Yuan W; Sun Z Immunology; 2021 Nov; 164(3):476-493. PubMed ID: 34322877 [TBL] [Abstract][Full Text] [Related]
17. Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer. Nyein AF; Bari S; Hogue S; Zhao Y; Maller B; Sha S; Gomez MF; Rollison DE; Robinson LA BMC Cancer; 2022 Jan; 22(1):101. PubMed ID: 35073876 [TBL] [Abstract][Full Text] [Related]
18. Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art. Andremont A; Cervesi J; Bandinelli PA; Vitry F; de Gunzburg J Drug Discov Today; 2021 Sep; 26(9):2159-2163. PubMed ID: 33639249 [TBL] [Abstract][Full Text] [Related]
19. Exploring the emerging role of the microbiome in cancer immunotherapy. Fessler J; Matson V; Gajewski TF J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949 [TBL] [Abstract][Full Text] [Related]
20. Bowel inflammation in cancer patients: the microbiome, antibiotics and interleukin-9. Halama N Br J Cancer; 2020 Nov; 123(10):1469-1470. PubMed ID: 32843683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]